Nick Savasta is Chief Executive Officer of Mercury Capital Asset Management. He is also Chief Investment Officer and Chairman of Mercury’s Investment Committee. He was previously Managing Director and Co-Head of the Strategic Investments Group at Michael Dell’s MSD Partners. Prior to that, Nick worked as a senior merchant banker with Allen & Company. He began his career as an investment banker in Morgan Stanley’s Corporate Finance Division. Nick has served on the Executive Board of the MIT Sloan School of Management. He has been a guest lecturer at Yale University, where he taught the school’s Introduction to Alternative Investments Seminar. He is a member of the Economic Club of New York and serves on The Contemporary Arts Council of The Museum of Modern Art. Nick serves on the Board of Overseers of Harvard University’s Beth Israel Deaconess Medical Center. He works closely with Harvard Medical School and is Co-Chairman of the Cancer Center Advisory Board at Beth Israel Deaconess Medical Center. In 2018, Nick was appointed to The Wall Street Journal CEO Council. He earned a B.S. in International Affairs from the Georgetown University School of Foreign Service with honors and received his MBA from MIT. He was a Fulbright Scholar and a Truman Fellow. Nick is a Chartered Alternative Investment Analyst (CAIA) Charter Holder. He is fluent in French, Italian and Arabic.